Search - tctmd.com

Displaying 341 - 360 of 386

Sort: Relevancy | Date

News Daily News

Diabetes Often Goes Unrecognized in Patients Hospitalized With Acute MI

May 07, 2015

News Daily News

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

L.A. McKeown

February 22, 2015

News Daily News

CREDO-Kyoto: Diabetic Patients With 3-Vessel or Left Main Disease Fare Better With CABG

February 08, 2015

News Daily News

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

Todd Neale

November 17, 2014

News Daily News

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

October 24, 2014

News Daily News

Acute Hyperglycemia Worsens Post-AMI Prognosis

October 24, 2014

News Conference News TCT 2014

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Todd Neale

October 17, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

News Daily News

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Caitlin E. Cox

October 03, 2014

Presentation TCT 2014

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

Presentation TCT 2014

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, John D. Puskas

September 16, 2014

Presentation TCT 2014

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, Frederick Feit

September 16, 2014

Presentation TCT 2014

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron

September 16, 2014

Presentation TCT 2014

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

News Daily News

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

May 30, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

Advertisement

Diabetes Often Goes Unrecognized in Patients Hospitalized With Acute MI

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

CREDO-Kyoto: Diabetic Patients With 3-Vessel or Left Main Disease Fare Better With CABG

El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

Acute Hyperglycemia Worsens Post-AMI Prognosis

Thoughtful Insights at TCT: Dealing With Complex CAD Cases

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

La Prueba de la Isquemia Predice el Pronóstico de Pacientes Diabéticos con EAC Asintomática

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Una Estrategia con Trimetazidina Reduce la NIC y la Lesión Miocárdica en Pacientes Diabéticos con ERC de Carácter entre Leve y Moderado

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content